You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
錦欣生殖(01951.HK)年度淨利潤同比增長36%,擬派末期息7.38港仙
格隆匯 03-30 23:28

格隆匯3月30日丨錦欣生殖(01951.HK)公佈截至2021年12月31日止年度業績,公司收益為人民幣14.26億元,同比增長28.9%;年度純利約為人民幣3.54億元,同比增長35.8%;每股基本盈利為人民幣0.14元,擬派末期股息每股7.38港仙。

公吿稱,收益整體增加主要由於集團的業務自COVID-19疫情中迅速恢復以及患者對生育治療的需求不斷提高所致。

2021年,隨着COVID-19疫情逐步受控,公司繼續全力專注於迅速恢復在大中華區及美國的當地業務,因而達致穩健的業務表現,收益較2020年增長28.9%。2021年,集團大中華區及美國業務營運所貢獻的收益分別較2020年增加31.8%及21.0%。公司2021年完成IVF治療週期數27,354個。西囡醫院集團及錦江生殖中心、深圳業務美國業務及武漢錦欣醫院分別實現55.3%/52.6%/56.2%/49.2%的成功率。

公司基於超卓的成功率、經驗豐富的強大醫務團隊、優質的患者護理服務和精練的管理團隊,繼續在ARS領域打造及提高良好的業務聲譽,藉此進一步鞏固公司作為大中華區及美國領先ARS供應商的地位。公司加快並執行增長及收購策略,繼而使公司的品牌在ARS市場中日益受到認同,因此,公司能夠吸引有需要的患者及ARS行業內的頂尖人才。公司能繼續擴展營運、增強患者體驗及忠誠度,以及提高在大中華區及美國市場的品牌知名度。

此外,憑藉公司具競爭力的核心業務ARS服務的優勢,公司進一步擴大服務範圍以提供涵蓋備孕、IVF、妊娠檢查、分娩及產後的全生育生命週期服務,從而為患者提供更好服務及為集團創造價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account